XIAP protein antagonists (Rockefeller University)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameXIAP protein antagonists (Rockefeller University)
Drug Alias NameXaripin-DXaripins (Rockefeller University)Xaripin-P
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInhibitor of apoptosis protein 3 inhibitors
TargetsInhibitor of apoptosis protein 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Rockefeller University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Rockefeller University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A